Skip to main content

Table 3 Diagnostic value of FibroTest for predicting Fibrosis in the two groups

From: Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

 

Group 1

Group 2

Cut-off of FibroTest

Sensitivity

Specificity

Positive Predictive

Value

Negative Predictive

Value

Sensitivity

Specificity

Positive Predictive

Value

Negative Predictive

Value

Stage F2F3F4

Prevalence = 0.24 (40/170)

  

Prevalence = 0.32 (31/97)

0.30

0.83 (33/40)

0.78 (101/130)

0.53 (33/62)

0.94 (101/108)

0.71 (22/31)

0.74 (49/66)

0.56 (22/39)

0.84 (49/58)

0.70

0.18 (7/40)

0.98 (128/130)

0.78 (7/9)

0.80 (128/161)

0.13 (4/31)

0.98 (65/66)

0.80 (4/5)

0.71 (65/92)

Stage F3F4

Prevalence = 0.12 (20/170)

  

Prevalence = 0.16 (16/97)

0.30

0.95 (19/20)

0.71 (107/150)

0.31 (19/62)

0.99 (107/108)

0.88 (14/16)

0.69 (56/81)

0.36 (14/39)

0.97 (56/58)

0.70

0.25 (5/20)

0.97 (146/150)

0.56 (5/9)

0.91 (146/161)

0.25 (4/16)

0.99 (80/81)

0.80 (4/5)

0.87 (80/92)

% of patients with FT between 0.30–0.70

0.32 (54/170)

   

0.35 (34/97)